{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:25:07Z","timestamp":1791224707284,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18KK0445"],"award-info":[{"award-number":["JP18KK0445"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-HL007627"],"award-info":[{"award-number":["T32-HL007627"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54-CA225088"],"award-info":[{"award-number":["U54-CA225088"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 CA256720"],"award-info":[{"award-number":["R21 CA256720"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA224193"],"award-info":[{"award-number":["CA224193"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","award":["1P50CA168504"],"award-info":[{"award-number":["1P50CA168504"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","award":["5R01CA226776"],"award-info":[{"award-number":["5R01CA226776"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018378","name":"Owens Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018378","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005615","name":"Beth Israel Deaconess Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20gm5910024"],"award-info":[{"award-number":["JP20gm5910024"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016394","name":"Ludwig Center at Harvard","doi-asserted-by":"publisher","award":["U54-CA225088"],"award-info":[{"award-number":["U54-CA225088"]}],"id":[{"id":"10.13039\/100016394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016394","name":"Ludwig Center at Harvard","doi-asserted-by":"publisher","award":["T32-HL007627"],"award-info":[{"award-number":["T32-HL007627"]}],"id":[{"id":"10.13039\/100016394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.cell.2021.07.020","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T10:32:54Z","timestamp":1628764374000},"page":"4753-4771.e27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":214,"title":["Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3208-9447","authenticated-orcid":false,"given":"Kazuhiro","family":"Koikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Kibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futoshi","family":"Suizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7705-036X","authenticated-orcid":false,"given":"Nobufumi","family":"Sekino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nami","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa D.","family":"Manz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benika J.","family":"Pinch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipikaa","family":"Akshinthala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9057-171X","authenticated-orcid":false,"given":"Ana","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5179-4256","authenticated-orcid":false,"given":"Giorgio","family":"Gaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Nezu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhong","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4792-1168","authenticated-orcid":false,"given":"Kenoki","family":"Ohuchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babara","family":"Wegiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Clohessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"London","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Santagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7868-6231","authenticated-orcid":false,"given":"Gerburg M.","family":"Wulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6564-9634","authenticated-orcid":false,"given":"Senthil K.","family":"Muthuswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5354-7403","authenticated-orcid":false,"given":"Nathanael S.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Zhen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun Ping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2021.07.020_bib1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/cancers9110157","article-title":"Pancreatic Cancer Chemoresistance to Gemcitabine","volume":"9","author":"Amrutkar","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cell.2021.07.020_bib106","first-page":"6244","article-title":"Pin1 is a novel prognostic marker in prostate cancer","volume":"63","author":"Ayala","year":"2003","journal-title":"Cancer Research"},{"key":"10.1016\/j.cell.2021.07.020_bib2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1053\/j.gastro.2004.12.036","article-title":"Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells","volume":"128","author":"Bachem","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cell.2021.07.020_bib3","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1053\/j.gastro.2018.12.038","article-title":"Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities","volume":"156","author":"Balachandran","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cell.2021.07.020_bib4","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0002-9440(10)63731-5","article-title":"Prevalent overexpression of prolyl isomerase Pin1 in human cancers","volume":"164","author":"Bao","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cell.2021.07.020_bib5","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ccr.2012.04.025","article-title":"Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T\u00a0cell immunity in pancreatic cancer","volume":"21","author":"Bayne","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2021.07.020_bib6","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/s41592-019-0582-9","article-title":"ilastik: interactive machine learning for (bio)image analysis","volume":"16","author":"Berg","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2021.07.020_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature11547","article-title":"Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes","volume":"491","author":"Biankin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.07.020_bib8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2021.07.020_bib9","doi-asserted-by":"crossref","first-page":"e101654","DOI":"10.15252\/embj.2019101654","article-title":"Xenograft and organoid model systems in cancer research","volume":"38","author":"Bleijs","year":"2019","journal-title":"EMBO J."},{"key":"10.1016\/j.cell.2021.07.020_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/35077225","article-title":"Oncogenic kinase signalling","volume":"411","author":"Blume-Jensen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.07.020_bib11","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2021.07.020_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature23643","article-title":"CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity","volume":"549","author":"Burr","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.07.020_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2019.09.030","article-title":"Mechanisms Controlling PD-L1 Expression in Cancer","volume":"76","author":"Cha","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2021.07.020_bib14","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1111\/cas.14085","article-title":"Targeting PIN1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis","volume":"110","author":"Chen","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cell.2021.07.020_bib15","doi-asserted-by":"crossref","first-page":"137809","DOI":"10.1172\/jci.insight.137809","article-title":"Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology","volume":"5","author":"Dantes","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.cell.2021.07.020_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2015.08.068","article-title":"Preclinical mouse cancer models: a maze of opportunities and challenges","volume":"163","author":"Day","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.07.020_bib17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrc2943","article-title":"Acute promyelocytic leukaemia: novel insights into the mechanisms of cure","volume":"10","author":"de Th\u00e9","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2021.07.020_bib18","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","article-title":"Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids","volume":"174","author":"Dijkstra","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.07.020_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.aae0477","article-title":"Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity","volume":"353","author":"Dorand","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.07.020_bib20","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1038\/s41596-019-0206-y","article-title":"Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging","volume":"14","author":"Du","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cell.2021.07.020_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41589-021-00786-7","article-title":"Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo","author":"Dubiella","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cell.2021.07.020_bib22","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1053\/j.gastro.2017.01.010","article-title":"Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mice","volume":"152","author":"Endo","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cell.2021.07.020_bib23","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1053\/j.gastro.2013.07.025","article-title":"Activated pancreatic stellate cells sequester CD8+ T\u00a0cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma","volume":"145","author":"Ene-Obong","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cell.2021.07.020_bib24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/gutjnl-2011-301220","article-title":"StellaTUM: current consensus and discussion on pancreatic stellate cell research","volume":"61","author":"Erkan","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.cell.2021.07.020_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/j.gastro.2008.09.067","article-title":"Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer","volume":"136","author":"Farrell","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cell.2021.07.020_bib26","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2021.07.020_bib27","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1053\/j.gastro.2011.06.047","article-title":"Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-beta-catenin signaling to slow tumor progression","volume":"141","author":"Froeling","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cell.2021.07.020_bib28","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1053\/j.gastro.2018.05.051","article-title":"NF\u03baB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12","volume":"155","author":"Garg","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cell.2021.07.020_bib29","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2021.07.020_bib30","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1158\/1078-0432.CCR-17-2733","article-title":"Personalized RNA Medicine for Pancreatic Cancer","volume":"24","author":"Gilles","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2021.07.020_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccr.2011.06.004","article-title":"A Pin1\/mutant p53 axis promotes aggressiveness in breast cancer","volume":"20","author":"Girardini","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2021.07.020_bib32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1042\/BST0380187","article-title":"The Sla2p\/HIP1\/HIP1R family: similar structure, similar function in endocytosis?","volume":"38","author":"Gottfried","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.cell.2021.07.020_bib33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrc.2017.17","article-title":"Prospects for combining targeted and conventional cancer therapy with immunotherapy","volume":"17","author":"Gotwals","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2021.07.020_bib34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.canlet.2013.12.006","article-title":"Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells","volume":"345","author":"Guan","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cell.2021.07.020_bib35","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.07.020_bib36","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.07.020_bib37","doi-asserted-by":"crossref","first-page":"e87415","DOI":"10.1172\/jci.insight.87415","article-title":"Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer","volume":"1","author":"Herter-Sprie","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.cell.2021.07.020_bib38","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","author":"Hingorani","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2021.07.020_bib39","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cell.2021.07.020_bib40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","article-title":"Pancreatic cancer stroma: an update on therapeutic targeting strategies","volume":"17","author":"Hosein","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cell.2021.07.020_bib41","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.3892\/or.2017.5856","article-title":"FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1","volume":"38","author":"Hu","year":"2017","journal-title":"Oncol. Rep."},{"issue":"W1","key":"10.1016\/j.cell.2021.07.020_bib42","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: visual analytics of multi-drug combination synergies","volume":"48","author":"Ianevski","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2021.07.020_bib43","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.clml.2013.08.004","article-title":"Single-agent liposomal all-trans-retinoic Acid as initial therapy for acute promyelocytic leukemia: 13-year follow-up data","volume":"14","author":"Jain","year":"2014","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.cell.2021.07.020_bib44","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nm.4123","article-title":"Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy","volume":"22","author":"Jiang","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2021.07.020_bib45","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1158\/1078-0432.CCR-16-3215","article-title":"PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression","volume":"23","author":"Jiao","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2021.07.020_bib46","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.cell.2021.07.020_bib47","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1038\/s41467-020-18636-w","article-title":"Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer","volume":"11","author":"Kocher","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2021.07.020_bib48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.canlet.2018.03.031","article-title":"Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma","volume":"425","author":"Koikawa","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cell.2021.07.020_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.canlet.2017.10.010","article-title":"Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180","volume":"412","author":"Koikawa","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cell.2021.07.020_bib102","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature14658","article-title":"Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy","volume":"523","author":"Kondo","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.07.020_bib50","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1038\/s41467-018-05402-2","article-title":"Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells","volume":"9","author":"Kozono","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2021.07.020_bib51","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nm.4082","article-title":"Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression","volume":"22","author":"Laklai","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2021.07.020_bib52","first-page":"1054","article-title":"Pharmacokinetics of oral all-trans retinoic acid in patients with acute promyelocytic leukemia","volume":"5","author":"Lefebvre","year":"1991","journal-title":"Leukemia"},{"key":"10.1016\/j.cell.2021.07.020_bib53","doi-asserted-by":"crossref","first-page":"e68148","DOI":"10.1371\/journal.pone.0068148","article-title":"The rs2233678 polymorphism in PIN1 promoter region reduced cancer risk: a meta-analysis","volume":"8","author":"Li","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cell.2021.07.020_bib54","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.csbj.2019.03.016","article-title":"Mouse-Derived Allografts: A Complementary Model to the KPC Mice on Researching Pancreatic Cancer In\u00a0Vivo","volume":"17","author":"Li","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.cell.2021.07.020_bib55","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ccell.2016.10.010","article-title":"Deubiquitination and Stabilization of PD-L1 by CSN5","volume":"30","author":"Lim","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2021.07.020_bib56","doi-asserted-by":"crossref","first-page":"e31657","DOI":"10.7554\/eLife.31657","article-title":"Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes","volume":"7","author":"Lin","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.cell.2021.07.020_bib57","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1073\/pnas.032404099","article-title":"Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes","volume":"99","author":"Liou","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2021.07.020_bib58","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41556-018-0260-7","article-title":"An IRAK1-PIN1 signalling axis drives intrinsic tumour resistance to radiation therapy","volume":"21","author":"Liu","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cell.2021.07.020_bib59","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/cr.2014.109","article-title":"Prolyl isomerase Pin1 in cancer","volume":"24","author":"Lu","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.cell.2021.07.020_bib60","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2009.02.024","article-title":"Principles of cancer therapy: oncogene and non-oncogene addiction","volume":"136","author":"Luo","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.07.020_bib61","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1158\/0008-5472.CAN-19-2739","article-title":"Inactivation of the prolyl isomerase Pin1 sensitizes BRCA1-proficient breast cancer to PARP inhibition","volume":"80","author":"Luo","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2021.07.020_bib62","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/gutjnl-2016-311585","article-title":"IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer","volume":"67","author":"Mace","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.cell.2021.07.020_bib63","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrd4591","article-title":"Combination cancer immunotherapy and new immunomodulatory targets","volume":"14","author":"Mahoney","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cell.2021.07.020_bib64","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/j.gastro.2012.06.006","article-title":"Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma","volume":"143","author":"Mar\u00e9chal","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cell.2021.07.020_bib65","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T\u00a0cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.07.020_bib66","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.07.020_bib67","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.cell.2017.10.001","article-title":"Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution","volume":"171","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.07.020_bib68","doi-asserted-by":"crossref","first-page":"e03311","DOI":"10.7554\/eLife.03311","article-title":"Epsin deficiency impairs endocytosis by stalling the actin-dependent invagination of endocytic clathrin-coated pits","volume":"3","author":"Messa","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.cell.2021.07.020_bib69","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature23669","article-title":"Identification of CMTM6 and CMTM4 as PD-L1 protein regulators","volume":"549","author":"Mezzadra","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.07.020_bib70","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41422-019-0162-7","article-title":"Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy","volume":"29","author":"Mugoni","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.cell.2021.07.020_bib71","first-page":"681","article-title":"PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer","volume":"1","author":"Oh","year":"2021","journal-title":"Nat. Can."},{"key":"10.1016\/j.cell.2021.07.020_bib72","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/ijc.31775","article-title":"Adipose tissue-derived stromal cells are sources of cancer-associated fibroblasts and enhance tumor progression by dense collagen matrix","volume":"144","author":"Okumura","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cell.2021.07.020_bib73","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2021.07.020_bib74","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1158\/2159-8290.CD-18-1218","article-title":"PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer","volume":"9","author":"Pantelidou","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2021.07.020_bib75","doi-asserted-by":"crossref","first-page":"14836","DOI":"10.1038\/ncomms14836","article-title":"A BaSiC tool for background and shading correction of optical microscopy images","volume":"8","author":"Peng","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2021.07.020_bib76","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2021.07.020_bib77","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41597-019-0332-y","article-title":"Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer","volume":"6","author":"Rashid","year":"2019","journal-title":"Sci. Data"},{"key":"10.1016\/j.cell.2021.07.020_bib78","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2021.07.020_bib79","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1158\/1078-0432.CCR-06-0113","article-title":"An in\u00a0vivo platform for translational drug development in pancreatic cancer","volume":"12","author":"Rubio-Viqueira","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2021.07.020_bib80","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.cell.2020.03.008","article-title":"Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer","volume":"181","author":"Ruscetti","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.07.020_bib81","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2021.07.020_bib82","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrgastro.2011.215","article-title":"The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma","volume":"9","author":"Samuel","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cell.2021.07.020_bib83","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.07.020_bib84","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cell.2014.08.007","article-title":"Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy","volume":"159","author":"Sherman","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.07.020_bib85","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-019-1130-6","article-title":"Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring","volume":"569","author":"Shi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.07.020_bib86","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cell.2021.07.020_bib87","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.15252\/embj.201593003","article-title":"Phosphorylation-dependent Akt-Inversin interaction at the basal body of primary cilia","volume":"35","author":"Suizu","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.cell.2021.07.020_bib88","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1186\/s12885-017-3634-5","article-title":"Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma","volume":"17","author":"Tessier-Cloutier","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cell.2021.07.020_bib89","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrm2203","article-title":"Mechanisms of specificity in protein phosphorylation","volume":"8","author":"Ubersax","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cell.2021.07.020_bib90","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature10624","article-title":"Natural killer cells act as rheostats modulating antiviral T\u00a0cells","volume":"481","author":"Waggoner","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.07.020_bib91","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41589-018-0161-x","article-title":"HIP1R targets PD-L1 to lysosomal degradation to alter T\u00a0cell-mediated cytotoxicity","volume":"15","author":"Wang","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cell.2021.07.020_bib92","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12943-020-01200-x","article-title":"The biomarkers of hyperprogressive disease in PD-1\/PD-L1 blockage therapy","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cell.2021.07.020_bib93","doi-asserted-by":"crossref","first-page":"a031435","DOI":"10.1101\/cshperspect.a031435","article-title":"KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer","volume":"8","author":"Waters","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.cell.2021.07.020_bib94","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nm.3839","article-title":"Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer","volume":"21","author":"Wei","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2021.07.020_bib95","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1053\/j.gastro.2018.12.044","article-title":"Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets","volume":"156","author":"Whittle","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cell.2021.07.020_bib96","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1038\/sj.emboj.7600323","article-title":"Modeling breast cancer in\u00a0vivo and ex\u00a0vivo reveals an essential role of Pin1 in tumorigenesis","volume":"23","author":"Wulf","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.cell.2021.07.020_bib105","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1093\/emboj\/20.13.3459","article-title":"Pin1 is overexpressed in breast cancer and potentiates the transcriptional activity of phosphorylated c-Jun towards the cyclin D1 gene","volume":"20","author":"Wulf","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.cell.2021.07.020_bib97","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s10147-017-1112-3","article-title":"PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8+ tumor-infiltrating lymphocytes: highly sensitive detection using phosphor-integrated dot staining","volume":"22","author":"Yamaki","year":"2017","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.cell.2021.07.020_bib98","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","article-title":"Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I","volume":"581","author":"Yamamoto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.07.020_bib99","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature25015","article-title":"Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance","volume":"553","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.07.020_bib100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrc.2016.49","article-title":"The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target","volume":"16","author":"Zhou","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2021.07.020_bib101","doi-asserted-by":"crossref","first-page":"328rv4","DOI":"10.1126\/scitranslmed.aad7118","article-title":"PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations","volume":"8","author":"Zou","year":"2016","journal-title":"Sci. Transl. Med."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867421008795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867421008795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:16:12Z","timestamp":1777475772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867421008795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":104,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0092867421008795"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2021.07.020","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740632689.793588207","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.740632689.793589876","asserted-by":"object"}]},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2021.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}